[HTML][HTML] Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization

DG Espinosa-Heidmann, A Caicedo… - … & visual science, 2003 - iovs.arvojournals.org
DG Espinosa-Heidmann, A Caicedo, EP Hernandez, KG Csaky, SW Cousins
Investigative ophthalmology & visual science, 2003iovs.arvojournals.org
P urpose. The pathogenesis of choroidal neovascularization (CNV) is postulated to be
driven by angiogenesis, a process in which the cellular components of the new vessel
complex are derived from cells resident within an adjacent preexisting capillary. Recently,
an alternative paradigm, termed postnatal vasculogenesis, has been shown to contribute to
some forms of neovascularization. In vasculogenesis, the cellular components of the new
vessel complex are derived from circulating vascular progenitors from bone marrow. In the …
Abstract
P urpose. The pathogenesis of choroidal neovascularization (CNV) is postulated to be driven by angiogenesis, a process in which the cellular components of the new vessel complex are derived from cells resident within an adjacent preexisting capillary. Recently, an alternative paradigm, termed postnatal vasculogenesis, has been shown to contribute to some forms of neovascularization. In vasculogenesis, the cellular components of the new vessel complex are derived from circulating vascular progenitors from bone marrow. In the current study, transplantation of green fluorescent protein (GFP)-labeled bone marrow and laser-induced CNV were combined to examine the contribution of vasculogenesis to the formation of CNV.
M ethods. Ten adult C57BL/6 female mice were used as recipients for bone marrow transplantation. Bone marrow was obtained from three C57BL/6 female mice transgenic for the β-actin promoter GFP. One month after bone marrow transplantation, CNV was induced in recipient mice by making four separate burns in the choroid of each eye with a red diode laser. Four weeks after CNV was induced, eyes of recipient mice were processed for immunohistochemistry to detect GFP and markers for vascular smooth muscle cells (α-smooth muscle actin, desmin, and NG2 chondroitin sulfate proteoglycan), endothelial cells (CD31, BS-1 lectin), or macrophages (F4/80).
R esults. GFP-labeled cells represented 17% of the total cell population in the lesion. Many of the GFP-labeled cells were immunoreactive for α-smooth muscle actin (39%), desmin, NG2, CD31 (41%), BS-1 lectin, or F4/80. GFP-labeled cells were morphologically indistinguishable from cells normally present in CNV lesions.
C onclusions. This study is the first to demonstrate that bone marrow-derived progenitor cells are a source of endothelial and smooth musclelike cells in CNV.
ARVO Journals